Presents a study which compared the maximum tolerated doses, the toxic effects, and the pharmacokinetics and pharmacodynamics of topotecan in patients who had refractory, malignant, solid tumors and who either had or lacked hepatic injury. Anticancer activity by topotecan; Method of study; Right dose of topotecan for the treatment of cancer patients with hepatic injury.